Eduardo Iyo
Palma, PM, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Effectiveness and Safety of First-Line Non-Bismuth Quadruple Concomitant Therapy Versus Single-Capsule Bismuth Quadruple Therapy.
Journal: Alimentary pharmacology & therapeutics
Published: March 26, 2025
Persistence, Effectiveness, and Safety of Upadacitinib in Crohn's Disease and Ulcerative Colitis in Real Life: Results From a Spanish Nationwide Study (Ureal Study).
Journal: The American journal of gastroenterology
Published: July 17, 2024
Long-term benefit of ustekinumab in ulcerative colitis in clinical practice: ULISES study.
Journal: Alimentary pharmacology & therapeutics
Published: June 09, 2024
Efficacy and safety of biological treatment for inflammatory bowel disease in elderly patients: Results from a GETECCU cohort.
Journal: Gastroenterologia y hepatologia
Published: October 31, 2023
Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety.
Journal: The American journal of gastroenterology
Published: July 13, 2022
Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn's Disease Patients on Ustekinumab.
Journal: Journal of clinical medicine
Published: June 10, 2022
Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study. J. Clin. Med. 2021, 10, 2885.
Journal: Journal of clinical medicine
Published: May 26, 2022
Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study.
Journal: Inflammatory bowel diseases
Published: September 10, 2021
Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study.
Journal: Journal of clinical medicine
Published: May 19, 2021
European Registry on Helicobacter pylori Management: Effectiveness of First and Second-Line Treatment in Spain.
Journal: Antibiotics (Basel, Switzerland)
Published: December 01, 2020
CA19-9 capability as predictor of pancreatic cancer resectability in a Spanish cohort.
Journal: Molecular biology reports
Published: October 14, 2019
Showing 1-12 of 12
Last Updated: 09/26/2026